The development of a second-generation triazene.
Wilman
D E
DE
Drug Development Section, Institute of Cancer Research, CRC Laboratory, Surrey, U.K.
D000818:Animals; D000970:Antineoplastic Agents; D004341:Drug Evaluation; D004364:Pharmaceutical Preparations; D011355:Prodrugs; D013329:Structure-Activity Relationship; D014226:Triazenes
D000970:Antineoplastic Agents; D004364:Pharmaceutical Preparations; D011355:Prodrugs; D014226:Triazenes; C030838:1-(4-carboxyphenyl)-3,3-dimethyltriazene